

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.50420747 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 8.30845534 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.59699455 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.59699455 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.25493114 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25493114 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.92817035 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.35890864 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.35890864 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.35890864 |
| 11 | drug metabolic process (GO:0017144) | 6.34063546 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.22818464 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.22385246 |
| 14 | oxidative demethylation (GO:0070989) | 6.21005176 |
| 15 | bile acid biosynthetic process (GO:0006699) | 6.15739321 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.96667688 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.73472311 |
| 18 | urea metabolic process (GO:0019627) | 5.71884706 |
| 19 | urea cycle (GO:0000050) | 5.71884706 |
| 20 | complement activation, alternative pathway (GO:0006957) | 5.67029180 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.66145633 |
| 22 | phenylpropanoid metabolic process (GO:0009698) | 5.65501232 |
| 23 | regulation of protein activation cascade (GO:2000257) | 5.62765575 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.49967149 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 5.47972300 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.44027695 |
| 27 | protein carboxylation (GO:0018214) | 5.44027695 |
| 28 | ethanol metabolic process (GO:0006067) | 5.37792402 |
| 29 | cysteine metabolic process (GO:0006534) | 5.32657466 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.31231813 |
| 31 | regulation of plasminogen activation (GO:0010755) | 5.31050418 |
| 32 | regulation of complement activation (GO:0030449) | 5.28108794 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.25692220 |
| 34 | * glyoxylate metabolic process (GO:0046487) | 5.25011140 |
| 35 | bile acid metabolic process (GO:0008206) | 5.19246177 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 5.10420027 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.03300408 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 5.02540061 |
| 39 | S-adenosylmethionine metabolic process (GO:0046500) | 4.97720647 |
| 40 | negative regulation of hemostasis (GO:1900047) | 4.93418819 |
| 41 | negative regulation of blood coagulation (GO:0030195) | 4.93418819 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.86313551 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.79821926 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.78264002 |
| 45 | homocysteine metabolic process (GO:0050667) | 4.76872038 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.76517721 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.71939915 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.71939915 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.71939915 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.65508982 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.62995446 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.62995446 |
| 53 | lysine metabolic process (GO:0006553) | 4.62359081 |
| 54 | lysine catabolic process (GO:0006554) | 4.62359081 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.58632703 |
| 56 | coenzyme catabolic process (GO:0009109) | 4.52933545 |
| 57 | alkaloid metabolic process (GO:0009820) | 4.52155499 |
| 58 | phospholipid efflux (GO:0033700) | 4.51425833 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 4.49640867 |
| 60 | negative regulation of coagulation (GO:0050819) | 4.48485738 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 4.47826589 |
| 62 | negative regulation of sterol transport (GO:0032372) | 4.47826589 |
| 63 | glycine metabolic process (GO:0006544) | 4.47668945 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.47104664 |
| 65 | negative regulation of wound healing (GO:0061045) | 4.44840805 |
| 66 | cellular ketone body metabolic process (GO:0046950) | 4.44613638 |
| 67 | amine catabolic process (GO:0009310) | 4.40259932 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 4.40259932 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.35356540 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 4.33073171 |
| 71 | regulation of humoral immune response (GO:0002920) | 4.28849093 |
| 72 | acute-phase response (GO:0006953) | 4.28823722 |
| 73 | cellular glucuronidation (GO:0052695) | 4.28068119 |
| 74 | cellular amino acid catabolic process (GO:0009063) | 4.27756421 |
| 75 | glutamate metabolic process (GO:0006536) | 4.24170221 |
| 76 | positive regulation of hemostasis (GO:1900048) | 4.23526871 |
| 77 | positive regulation of blood coagulation (GO:0030194) | 4.23526871 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 4.19942193 |
| 79 | cholesterol efflux (GO:0033344) | 4.19025102 |
| 80 | ethanol oxidation (GO:0006069) | 4.17679005 |
| 81 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.16168726 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 4.15203238 |
| 83 | negative regulation of protein activation cascade (GO:2000258) | 4.12908555 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09755269 |
| 85 | hormone catabolic process (GO:0042447) | 4.09328111 |
| 86 | cellular modified amino acid catabolic process (GO:0042219) | 4.06225390 |
| 87 | fibrinolysis (GO:0042730) | 4.06114457 |
| 88 | intestinal cholesterol absorption (GO:0030299) | 4.03359683 |
| 89 | cytolysis (GO:0019835) | 4.03125907 |
| 90 | arginine metabolic process (GO:0006525) | 4.01294364 |
| 91 | aldehyde catabolic process (GO:0046185) | 4.00343449 |
| 92 | serine family amino acid biosynthetic process (GO:0009070) | 4.00297605 |
| 93 | complement activation, classical pathway (GO:0006958) | 3.98108520 |
| 94 | plasma lipoprotein particle assembly (GO:0034377) | 3.94913364 |
| 95 | low-density lipoprotein particle remodeling (GO:0034374) | 3.94518937 |
| 96 | daunorubicin metabolic process (GO:0044597) | 3.92949443 |
| 97 | polyketide metabolic process (GO:0030638) | 3.92949443 |
| 98 | doxorubicin metabolic process (GO:0044598) | 3.92949443 |
| 99 | blood coagulation, intrinsic pathway (GO:0007597) | 3.92444510 |
| 100 | complement activation (GO:0006956) | 3.91296073 |
| 101 | positive regulation of coagulation (GO:0050820) | 3.91109112 |
| 102 | flavonoid metabolic process (GO:0009812) | 3.90771334 |
| 103 | protein activation cascade (GO:0072376) | 3.85858103 |
| 104 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.85711580 |
| 105 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.85711580 |
| 106 | cofactor catabolic process (GO:0051187) | 3.85681345 |
| 107 | ketone body metabolic process (GO:1902224) | 3.84895466 |
| 108 | heme transport (GO:0015886) | 3.83976564 |
| 109 | opsonization (GO:0008228) | 3.83245061 |
| 110 | response to mercury ion (GO:0046689) | 3.80704525 |
| 111 | uronic acid metabolic process (GO:0006063) | 3.79700383 |
| 112 | glucuronate metabolic process (GO:0019585) | 3.79700383 |
| 113 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.78033458 |
| 114 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.78033458 |
| 115 | phospholipid homeostasis (GO:0055091) | 3.77970306 |
| 116 | acetyl-CoA metabolic process (GO:0006084) | 3.76844611 |
| 117 | positive regulation of lipid catabolic process (GO:0050996) | 3.74137126 |
| 118 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73073931 |
| 119 | cholesterol homeostasis (GO:0042632) | 3.72425840 |
| 120 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71302589 |
| 121 | xenobiotic metabolic process (GO:0006805) | 3.71209533 |
| 122 | * organic acid catabolic process (GO:0016054) | 3.70438327 |
| 123 | * carboxylic acid catabolic process (GO:0046395) | 3.70438327 |
| 124 | negative regulation of lipase activity (GO:0060192) | 3.68007970 |
| 125 | drug catabolic process (GO:0042737) | 3.66937416 |
| 126 | sterol homeostasis (GO:0055092) | 3.66265522 |
| 127 | regulation of cholesterol homeostasis (GO:2000188) | 3.65732537 |
| 128 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.64016556 |
| 129 | short-chain fatty acid metabolic process (GO:0046459) | 3.60359721 |
| 130 | NAD biosynthetic process (GO:0009435) | 3.58964445 |
| 131 | plasma lipoprotein particle organization (GO:0071827) | 3.58428899 |
| 132 | steroid catabolic process (GO:0006706) | 3.57738102 |
| 133 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.55797374 |
| 134 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55797374 |
| 135 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.51767611 |
| 136 | exogenous drug catabolic process (GO:0042738) | 10.0672656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.38898853 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20842877 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.11657693 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51817341 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.32457444 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.09309061 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.75199281 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.08149919 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.00072407 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06831093 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0114566 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96359700 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94974507 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62060261 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.59717586 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52503763 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43732492 |
| 18 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40641344 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25479409 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24010616 |
| 21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21555219 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17971101 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07950664 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04157958 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01973104 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97686668 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96086840 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95492245 |
| 29 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88772895 |
| 30 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.88380375 |
| 31 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.87123658 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86976611 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85396213 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84770457 |
| 35 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83415358 |
| 36 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.82386621 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81500985 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79465634 |
| 39 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78384352 |
| 40 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78105609 |
| 41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77408639 |
| 42 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77277314 |
| 43 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.77019543 |
| 44 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.76892541 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76200185 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75896312 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.75875152 |
| 48 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.75477947 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74980102 |
| 50 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74784947 |
| 51 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74235971 |
| 52 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.73881711 |
| 53 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72221744 |
| 54 | NFYA_21822215_ChIP-Seq_K562_Human | 0.70447879 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69105704 |
| 56 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68847464 |
| 57 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68816230 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67858166 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67858166 |
| 60 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.67645756 |
| 61 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.66866217 |
| 62 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64383999 |
| 63 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63914514 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63057457 |
| 65 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61143715 |
| 66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61126323 |
| 67 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.60984257 |
| 68 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.60190938 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.59672366 |
| 70 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.59632444 |
| 71 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.59549304 |
| 72 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56838496 |
| 73 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56837200 |
| 74 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.56634852 |
| 75 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.56575241 |
| 76 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55956154 |
| 77 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.54642781 |
| 78 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.53678246 |
| 79 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53636955 |
| 80 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53296630 |
| 81 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.52711793 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.52381554 |
| 83 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52243575 |
| 84 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.52097117 |
| 85 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51911781 |
| 86 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.51764100 |
| 87 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.51607730 |
| 88 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51586501 |
| 89 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.51444932 |
| 90 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50261830 |
| 91 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.50136935 |
| 92 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.50055680 |
| 93 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49441293 |
| 94 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.49029454 |
| 95 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.48986275 |
| 96 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48922466 |
| 97 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.48739960 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.48664079 |
| 99 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.48648887 |
| 100 | NFYB_21822215_ChIP-Seq_K562_Human | 0.48054143 |
| 101 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.47934107 |
| 102 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47714072 |
| 103 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.47105336 |
| 104 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46775628 |
| 105 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.46741009 |
| 106 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.46066962 |
| 107 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45965485 |
| 108 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.45847946 |
| 109 | * ERG_20517297_ChIP-Seq_VCAP_Human | 0.45620020 |
| 110 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44873433 |
| 111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44318495 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.44141781 |
| 113 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.42711997 |
| 114 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.42150773 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41899037 |
| 116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41694526 |
| 117 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41546259 |
| 118 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.40496766 |
| 119 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.39699939 |
| 120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39515518 |
| 121 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.39478575 |
| 122 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39135985 |
| 123 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38490259 |
| 124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38315464 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.38092575 |
| 126 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.37794651 |
| 127 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.37764619 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37744385 |
| 129 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37448318 |
| 130 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36876629 |
| 131 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36333800 |
| 132 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.35902806 |
| 133 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35808178 |
| 134 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34440324 |
| 135 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34087909 |
| 136 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33356961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.33833152 |
| 2 | MP0005360_urolithiasis | 7.56447849 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.54206458 |
| 4 | MP0005365_abnormal_bile_salt | 6.22678995 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.95400080 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.32309065 |
| 7 | MP0003252_abnormal_bile_duct | 3.99132610 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.58847579 |
| 9 | MP0009840_abnormal_foam_cell | 3.20207096 |
| 10 | MP0005083_abnormal_biliary_tract | 3.12896907 |
| 11 | MP0003195_calcinosis | 2.78480028 |
| 12 | MP0005332_abnormal_amino_acid | 2.71504478 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.61058971 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.30911876 |
| 15 | MP0000609_abnormal_liver_physiology | 2.17567024 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.10260100 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.08370598 |
| 18 | MP0003868_abnormal_feces_composition | 1.98317949 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.96030359 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83097844 |
| 21 | MP0001764_abnormal_homeostasis | 1.65733527 |
| 22 | MP0009697_abnormal_copulation | 1.61901979 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55928091 |
| 24 | MP0003011_delayed_dark_adaptation | 1.39991924 |
| 25 | MP0005451_abnormal_body_composition | 1.32842203 |
| 26 | MP0003186_abnormal_redox_activity | 1.24044603 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.23150379 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.19626899 |
| 29 | MP0005647_abnormal_sex_gland | 1.19610082 |
| 30 | MP0000598_abnormal_liver_morphology | 1.18119888 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.16510613 |
| 32 | MP0000604_amyloidosis | 1.06360405 |
| 33 | MP0009764_decreased_sensitivity_to | 1.05088718 |
| 34 | MP0002254_reproductive_system_inflammat | 1.02466570 |
| 35 | MP0009763_increased_sensitivity_to | 1.02433586 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.01228910 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 0.90703387 |
| 38 | MP0008469_abnormal_protein_level | 0.89769516 |
| 39 | MP0009642_abnormal_blood_homeostasis | 0.86157738 |
| 40 | MP0005408_hypopigmentation | 0.83706436 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 0.82109956 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 0.80211411 |
| 43 | MP0005187_abnormal_penis_morphology | 0.80040984 |
| 44 | MP0005376_homeostasis/metabolism_phenot | 0.79582883 |
| 45 | MP0005670_abnormal_white_adipose | 0.78577817 |
| 46 | MP0001915_intracranial_hemorrhage | 0.77212193 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 0.76889054 |
| 48 | MP0009765_abnormal_xenobiotic_induced | 0.76730160 |
| 49 | MP0005220_abnormal_exocrine_pancreas | 0.76588553 |
| 50 | MP0002876_abnormal_thyroid_physiology | 0.76472727 |
| 51 | MP0003879_abnormal_hair_cell | 0.71138764 |
| 52 | MP0004130_abnormal_muscle_cell | 0.70860916 |
| 53 | MP0002971_abnormal_brown_adipose | 0.70823367 |
| 54 | MP0005334_abnormal_fat_pad | 0.68851699 |
| 55 | MP0005535_abnormal_body_temperature | 0.67944273 |
| 56 | MP0003690_abnormal_glial_cell | 0.66978355 |
| 57 | MP0005266_abnormal_metabolism | 0.64975235 |
| 58 | MP0001661_extended_life_span | 0.64449892 |
| 59 | MP0009053_abnormal_anal_canal | 0.63433564 |
| 60 | MP0000639_abnormal_adrenal_gland | 0.60324590 |
| 61 | MP0002282_abnormal_trachea_morphology | 0.59460224 |
| 62 | MP0003329_amyloid_beta_deposits | 0.58945187 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 0.58472869 |
| 64 | MP0001756_abnormal_urination | 0.55230992 |
| 65 | MP0004381_abnormal_hair_follicle | 0.53862489 |
| 66 | MP0005448_abnormal_energy_balance | 0.53714321 |
| 67 | MP0005464_abnormal_platelet_physiology | 0.52361804 |
| 68 | MP0002928_abnormal_bile_duct | 0.50545733 |
| 69 | MP0005023_abnormal_wound_healing | 0.49373739 |
| 70 | MP0005058_abnormal_lysosome_morphology | 0.48185688 |
| 71 | MP0005395_other_phenotype | 0.47566523 |
| 72 | MP0002822_catalepsy | 0.47159435 |
| 73 | MP0003724_increased_susceptibility_to | 0.45078138 |
| 74 | MP0002249_abnormal_larynx_morphology | 0.44982947 |
| 75 | MP0003718_maternal_effect | 0.44150502 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.44000145 |
| 77 | MP0008873_increased_physiological_sensi | 0.43223051 |
| 78 | MP0003436_decreased_susceptibility_to | 0.42629291 |
| 79 | MP0008874_decreased_physiological_sensi | 0.42439105 |
| 80 | MP0002136_abnormal_kidney_physiology | 0.42410520 |
| 81 | MP0000579_abnormal_nail_morphology | 0.42324613 |
| 82 | MP0009384_cardiac_valve_regurgitation | 0.42299407 |
| 83 | MP0009785_altered_susceptibility_to | 0.42053165 |
| 84 | MP0005166_decreased_susceptibility_to | 0.41954259 |
| 85 | MP0003075_altered_response_to | 0.40395498 |
| 86 | MP0002837_dystrophic_cardiac_calcinosis | 0.39493348 |
| 87 | MP0003953_abnormal_hormone_level | 0.39412998 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 0.38894235 |
| 89 | MP0005248_abnormal_Harderian_gland | 0.37772985 |
| 90 | MP0005666_abnormal_adipose_tissue | 0.36436282 |
| 91 | MP0002796_impaired_skin_barrier | 0.36180089 |
| 92 | MP0009672_abnormal_birth_weight | 0.34937847 |
| 93 | MP0009115_abnormal_fat_cell | 0.32122587 |
| 94 | MP0006082_CNS_inflammation | 0.31886362 |
| 95 | MP0008872_abnormal_physiological_respon | 0.31678712 |
| 96 | MP0000249_abnormal_blood_vessel | 0.30716803 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.30703814 |
| 98 | MP0000467_abnormal_esophagus_morphology | 0.30694074 |
| 99 | MP0004883_abnormal_blood_vessel | 0.30549739 |
| 100 | MP0001853_heart_inflammation | 0.30508572 |
| 101 | MP0002970_abnormal_white_adipose | 0.30368807 |
| 102 | MP0001243_abnormal_dermal_layer | 0.29780885 |
| 103 | MP0001881_abnormal_mammary_gland | 0.29681818 |
| 104 | MP0002168_other_aberrant_phenotype | 0.29570892 |
| 105 | MP0001845_abnormal_inflammatory_respons | 0.27911825 |
| 106 | MP0000427_abnormal_hair_cycle | 0.26961053 |
| 107 | MP0002132_abnormal_respiratory_system | 0.26561952 |
| 108 | MP0001944_abnormal_pancreas_morphology | 0.25693268 |
| 109 | MP0002060_abnormal_skin_morphology | 0.25640823 |
| 110 | MP0005164_abnormal_response_to | 0.24933407 |
| 111 | MP0001851_eye_inflammation | 0.24910543 |
| 112 | MP0003959_abnormal_lean_body | 0.24347674 |
| 113 | MP0004142_abnormal_muscle_tone | 0.22933636 |
| 114 | MP0002332_abnormal_exercise_endurance | 0.22412750 |
| 115 | MP0005197_abnormal_uvea_morphology | 0.21360421 |
| 116 | MP0003632_abnormal_nervous_system | 0.20207556 |
| 117 | MP0002909_abnormal_adrenal_gland | 0.19358112 |
| 118 | MP0000566_synostosis | 0.17952304 |
| 119 | MP0002090_abnormal_vision | 0.16758997 |
| 120 | MP0000920_abnormal_myelination | 0.16093544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.52986807 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.45699582 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.31813349 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.70400514 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64445113 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.43104138 |
| 7 | Xanthomatosis (HP:0000991) | 6.27861323 |
| 8 | Complement deficiency (HP:0004431) | 5.84494631 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.49787349 |
| 10 | Joint hemorrhage (HP:0005261) | 4.83669500 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.80564497 |
| 12 | Epidermoid cyst (HP:0200040) | 4.58789595 |
| 13 | Hyperammonemia (HP:0001987) | 4.57024918 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.56822352 |
| 15 | Hyperglycinemia (HP:0002154) | 4.47327243 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.38849529 |
| 17 | Abnormality of complement system (HP:0005339) | 4.27412634 |
| 18 | Fat malabsorption (HP:0002630) | 4.25831196 |
| 19 | Ketosis (HP:0001946) | 4.23129660 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 4.21286813 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.18781229 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.18416376 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.05829280 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.03355409 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.86705940 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.86189557 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.86189557 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.85113489 |
| 29 | Hyperglycinuria (HP:0003108) | 3.83919376 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.79291604 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.77379780 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.56677059 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36637875 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.32241100 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.29993020 |
| 36 | Steatorrhea (HP:0002570) | 3.23819773 |
| 37 | Spontaneous abortion (HP:0005268) | 3.13435568 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.07855393 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.06677256 |
| 40 | Hypochromic microcytic anemia (HP:0004840) | 3.05602711 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.01242245 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 3.00336142 |
| 43 | Myocardial infarction (HP:0001658) | 2.99115833 |
| 44 | Ketoacidosis (HP:0001993) | 2.98462180 |
| 45 | Systemic lupus erythematosus (HP:0002725) | 2.93083586 |
| 46 | Skin nodule (HP:0200036) | 2.83276371 |
| 47 | Osteomalacia (HP:0002749) | 2.79686267 |
| 48 | Metabolic acidosis (HP:0001942) | 2.70620344 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.67217754 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.62217566 |
| 51 | Acanthocytosis (HP:0001927) | 2.60693322 |
| 52 | Lethargy (HP:0001254) | 2.56141993 |
| 53 | Purpura (HP:0000979) | 2.53044438 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.51996636 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.51996636 |
| 56 | Vascular calcification (HP:0004934) | 2.51779098 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.50049886 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.49181179 |
| 59 | Spastic diplegia (HP:0001264) | 2.46602938 |
| 60 | Fair hair (HP:0002286) | 2.44448992 |
| 61 | Glomerulonephritis (HP:0000099) | 2.42780545 |
| 62 | Cholelithiasis (HP:0001081) | 2.42774149 |
| 63 | Gout (HP:0001997) | 2.41262139 |
| 64 | Mitral stenosis (HP:0001718) | 2.41174068 |
| 65 | Abnormal gallbladder physiology (HP:0012438) | 2.40683001 |
| 66 | Cholecystitis (HP:0001082) | 2.40683001 |
| 67 | Cerebral edema (HP:0002181) | 2.39103337 |
| 68 | Neonatal onset (HP:0003623) | 2.38300691 |
| 69 | Pulmonary embolism (HP:0002204) | 2.37052208 |
| 70 | Hyperphosphaturia (HP:0003109) | 2.33729181 |
| 71 | Neonatal hypoglycemia (HP:0001998) | 2.33607852 |
| 72 | Irritability (HP:0000737) | 2.32144785 |
| 73 | Reduced antithrombin III activity (HP:0001976) | 2.30391582 |
| 74 | Amyloidosis (HP:0011034) | 2.29341343 |
| 75 | Gingival bleeding (HP:0000225) | 2.26926034 |
| 76 | Cardiovascular calcification (HP:0011915) | 2.23221991 |
| 77 | Malnutrition (HP:0004395) | 2.21709921 |
| 78 | Sensorimotor neuropathy (HP:0007141) | 2.20850603 |
| 79 | Esophageal varix (HP:0002040) | 2.19278261 |
| 80 | Abnormality of urine glucose concentration (HP:0011016) | 2.15876523 |
| 81 | Glycosuria (HP:0003076) | 2.15876523 |
| 82 | Menorrhagia (HP:0000132) | 2.13814624 |
| 83 | Pancreatitis (HP:0001733) | 2.13505232 |
| 84 | Brushfield spots (HP:0001088) | 2.11257411 |
| 85 | Thrombophlebitis (HP:0004418) | 2.10807225 |
| 86 | Arthropathy (HP:0003040) | 2.10307705 |
| 87 | Late onset (HP:0003584) | 2.09736983 |
| 88 | Bifid scrotum (HP:0000048) | 2.09471868 |
| 89 | Enlarged kidneys (HP:0000105) | 2.08999690 |
| 90 | Abnormality of the Achilles tendon (HP:0005109) | 2.08975036 |
| 91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03811471 |
| 92 | Abnormality of the gallbladder (HP:0005264) | 2.03395750 |
| 93 | Vomiting (HP:0002013) | 2.02148605 |
| 94 | Opisthotonus (HP:0002179) | 2.01832830 |
| 95 | Hemorrhage of the eye (HP:0011885) | 2.00020600 |
| 96 | Poikilocytosis (HP:0004447) | 1.99767474 |
| 97 | Generalized aminoaciduria (HP:0002909) | 1.96145294 |
| 98 | Increased mean platelet volume (HP:0011877) | 1.92730226 |
| 99 | Elevated alkaline phosphatase (HP:0003155) | 1.92116489 |
| 100 | Rickets (HP:0002748) | 1.91972417 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 1.89643483 |
| 102 | Abnormal urine phosphate concentration (HP:0012599) | 1.87265286 |
| 103 | Abnormal cartilage morphology (HP:0002763) | 1.86916018 |
| 104 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86450353 |
| 105 | Joint swelling (HP:0001386) | 1.86393577 |
| 106 | Renal cortical cysts (HP:0000803) | 1.84876698 |
| 107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83856429 |
| 108 | Elevated hepatic transaminases (HP:0002910) | 1.82453132 |
| 109 | Hypophosphatemic rickets (HP:0004912) | 1.81054637 |
| 110 | Status epilepticus (HP:0002133) | 1.77815039 |
| 111 | Hyperglycemia (HP:0003074) | 1.76056076 |
| 112 | Gangrene (HP:0100758) | 1.74973282 |
| 113 | Hydroxyprolinuria (HP:0003080) | 1.74322625 |
| 114 | Abnormality of proline metabolism (HP:0010907) | 1.74322625 |
| 115 | Abnormal platelet volume (HP:0011876) | 1.74033556 |
| 116 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.73548294 |
| 117 | Nephritis (HP:0000123) | 1.72399283 |
| 118 | Abnormality of vitamin metabolism (HP:0100508) | 1.72189122 |
| 119 | Alkalosis (HP:0001948) | 1.72112056 |
| 120 | Increased serum ferritin (HP:0003281) | 1.70008355 |
| 121 | Generalized hypopigmentation of hair (HP:0011358) | 1.69547824 |
| 122 | Epistaxis (HP:0000421) | 1.64991409 |
| 123 | Impaired platelet aggregation (HP:0003540) | 1.63722511 |
| 124 | Abnormal platelet function (HP:0011869) | 1.63722511 |
| 125 | Atrioventricular block (HP:0001678) | 1.61705135 |
| 126 | Cerebral palsy (HP:0100021) | 1.58886607 |
| 127 | Reticulocytosis (HP:0001923) | 1.51345349 |
| 128 | Abnormal biliary tract physiology (HP:0012439) | 1.51319477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.00520149 |
| 2 | FGFR4 | 4.60843455 |
| 3 | ERN1 | 4.59233093 |
| 4 | SIK1 | 4.43289658 |
| 5 | ERBB4 | 3.34737837 |
| 6 | TAOK3 | 3.21706539 |
| 7 | INSRR | 2.98370357 |
| 8 | MAP3K2 | 2.53458434 |
| 9 | MAP2K4 | 2.36523991 |
| 10 | PRPF4B | 2.13071591 |
| 11 | MST1R | 2.10821490 |
| 12 | PKN2 | 2.09256839 |
| 13 | MAPK11 | 2.04106831 |
| 14 | NTRK3 | 1.93242321 |
| 15 | FLT3 | 1.86201133 |
| 16 | PIK3CG | 1.84332729 |
| 17 | LATS1 | 1.76642300 |
| 18 | TYK2 | 1.70737855 |
| 19 | TRIB3 | 1.67348390 |
| 20 | DAPK2 | 1.52756782 |
| 21 | ABL2 | 1.48769258 |
| 22 | NEK9 | 1.46308980 |
| 23 | PTK6 | 1.44957179 |
| 24 | FRK | 1.41047875 |
| 25 | FGFR2 | 1.40565679 |
| 26 | MAP3K12 | 1.39065191 |
| 27 | KDR | 1.29840699 |
| 28 | TNK2 | 1.28471171 |
| 29 | JAK2 | 1.28002507 |
| 30 | MYLK | 1.24219960 |
| 31 | MAP3K7 | 1.22754902 |
| 32 | NLK | 1.16257264 |
| 33 | ARAF | 1.15718724 |
| 34 | ERBB2 | 1.13722848 |
| 35 | PRKAA2 | 1.11644048 |
| 36 | PINK1 | 1.07715667 |
| 37 | JAK1 | 1.06128542 |
| 38 | GRK6 | 1.04590180 |
| 39 | TBK1 | 1.04127093 |
| 40 | MAP2K3 | 1.01567282 |
| 41 | MAPK4 | 1.00787862 |
| 42 | MAP3K14 | 1.00342010 |
| 43 | FER | 0.99614071 |
| 44 | MAP3K10 | 0.99569278 |
| 45 | CAMKK2 | 0.97412364 |
| 46 | PRKG1 | 0.92192679 |
| 47 | PRKCZ | 0.90527224 |
| 48 | EPHA3 | 0.86772466 |
| 49 | PRKACA | 0.86646074 |
| 50 | MET | 0.86226932 |
| 51 | STK38L | 0.85842979 |
| 52 | MAPK15 | 0.85829298 |
| 53 | EPHB1 | 0.84968706 |
| 54 | MAP3K9 | 0.84321463 |
| 55 | MAP3K3 | 0.82546836 |
| 56 | CDK6 | 0.81998632 |
| 57 | MAPK12 | 0.79159098 |
| 58 | KSR2 | 0.78792449 |
| 59 | CAMK2G | 0.76764995 |
| 60 | PRKACG | 0.75846018 |
| 61 | TIE1 | 0.74394601 |
| 62 | ZAP70 | 0.73888993 |
| 63 | EIF2AK1 | 0.73746661 |
| 64 | CAMK1D | 0.73303908 |
| 65 | CSNK1D | 0.72366406 |
| 66 | MAP3K11 | 0.69966294 |
| 67 | GSK3A | 0.67115486 |
| 68 | DYRK1B | 0.66425303 |
| 69 | SCYL2 | 0.66205198 |
| 70 | CSK | 0.66091176 |
| 71 | PRKAA1 | 0.65669455 |
| 72 | RIPK1 | 0.65093397 |
| 73 | IRAK3 | 0.63539172 |
| 74 | PRKCB | 0.62987701 |
| 75 | SGK3 | 0.62139853 |
| 76 | MAP4K2 | 0.61541067 |
| 77 | MAP2K6 | 0.61393157 |
| 78 | SGK1 | 0.61125385 |
| 79 | PIM2 | 0.60881137 |
| 80 | FGFR3 | 0.60845827 |
| 81 | PKN1 | 0.58482607 |
| 82 | MAPK7 | 0.57673750 |
| 83 | CSF1R | 0.57301909 |
| 84 | RPS6KA3 | 0.56288767 |
| 85 | IKBKE | 0.52834178 |
| 86 | TGFBR2 | 0.52709482 |
| 87 | PTK2 | 0.52275582 |
| 88 | PRKCQ | 0.50505337 |
| 89 | CASK | 0.49332913 |
| 90 | PDPK1 | 0.49288059 |
| 91 | STK16 | 0.48484597 |
| 92 | PRKACB | 0.47876677 |
| 93 | SRC | 0.47097918 |
| 94 | CSNK1G1 | 0.46584207 |
| 95 | CSNK1E | 0.46459964 |
| 96 | SGK2 | 0.45519771 |
| 97 | IGF1R | 0.44921772 |
| 98 | MAP3K5 | 0.44593142 |
| 99 | PDK2 | 0.42597293 |
| 100 | RET | 0.42506965 |
| 101 | GRK1 | 0.41508098 |
| 102 | CDK4 | 0.40769095 |
| 103 | MAP3K13 | 0.40531504 |
| 104 | EPHA4 | 0.40244270 |
| 105 | MAP2K1 | 0.39847059 |
| 106 | EGFR | 0.38960015 |
| 107 | PRKCG | 0.38877853 |
| 108 | TAOK2 | 0.38463470 |
| 109 | MAP3K6 | 0.37848158 |
| 110 | WNK3 | 0.37388130 |
| 111 | ICK | 0.37315771 |
| 112 | MTOR | 0.35451081 |
| 113 | MAPKAPK3 | 0.35119949 |
| 114 | CSNK1A1 | 0.34371064 |
| 115 | PBK | 0.33448197 |
| 116 | CAMK4 | 0.32273337 |
| 117 | PDK1 | 0.30027055 |
| 118 | LATS2 | 0.29859635 |
| 119 | SGK494 | 0.29741969 |
| 120 | SGK223 | 0.29741969 |
| 121 | IRAK1 | 0.29356890 |
| 122 | CAMK1G | 0.28485976 |
| 123 | MAP3K1 | 0.28379710 |
| 124 | CSNK1G2 | 0.25844048 |
| 125 | PRKCA | 0.25265997 |
| 126 | PIK3CA | 0.25171573 |
| 127 | IRAK2 | 0.24359594 |
| 128 | ABL1 | 0.23718168 |
| 129 | CSNK1G3 | 0.22131888 |
| 130 | PAK3 | 0.21547780 |
| 131 | BMX | 0.21378907 |
| 132 | PDK3 | 0.21139229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.71120175 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.59104968 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.41100234 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30243337 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06345952 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.88133177 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71374969 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68860761 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54877381 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50908839 |
| 11 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.48020669 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38845518 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20909714 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16256918 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07712605 |
| 16 | * Peroxisome_Homo sapiens_hsa04146 | 2.04883978 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92940818 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91179801 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90212826 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88916916 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88236426 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86936429 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82550449 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80226784 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75919368 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73370760 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70093921 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69196444 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67563762 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66049500 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59447908 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59260117 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56451094 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.49144450 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48934358 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48631743 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46591375 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36323913 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35285106 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33002939 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30761234 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28755945 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.20452798 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20079235 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19469768 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18862623 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16252949 |
| 48 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.06664115 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05368041 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04925606 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04719566 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95947758 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94745541 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94674902 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92878636 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87694263 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84390782 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.81126159 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80742825 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76670548 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70408695 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66052638 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63355911 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58213546 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56198087 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.48493817 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45224047 |
| 68 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45030297 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44583340 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.27643220 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26348698 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25157080 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23465771 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.23455613 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22782496 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18933047 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18176840 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15333869 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11442418 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01966108 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2679395 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2436927 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2381724 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2340036 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2338973 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | -0.2307609 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2247842 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2205532 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | -0.2048605 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1978344 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1965387 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1944881 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1934907 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1737443 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1731009 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1725842 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | -0.1657280 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1547755 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1419387 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1386543 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1322772 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0954511 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0898134 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | -0.0784036 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0781613 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0765687 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0735157 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0509564 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0098330 |
| 110 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0081276 |

